TNFAIP3 and psoriasis: The response of psoriasis patients to USTEKINUMAB was associated with Tnfaip3 gene polymorphism31, implying that the pharmacotherapeutic effect exerted by USTEKINUMAB might be depend to some extent on the expression of Tnfaip3 or its protein function.